The second semester of the second CSO year is mainly devoted to those tumor entities that are closely related to surgical treatment procedures. These include the more common cancers of the lung (NSCLC and SCLC), colorectal carcinoma and prostate carcinoma. Furthermore, tumors of the pancreas as well as the stomach and esophagus are discussed. Tumors of the endocrine system are also treated; in addition to the less common thyroid tumors, the rather rare neuroendocrine tumors are also an issue.

To introduce and expand knowledge in the field of imaging diagnostics, a seminar of the same name takes place, which has the task of explaining some of the aforementioned cancers using X-ray or CT images.

In addition to these subject areas, psycho-oncology is addressed, among other things, communication methods and the 'conveying of bad news'.

The last year of the oncology focus curriculum deals with clinical subjects that have an oncological component, such as Urology, pediatrics, ENT, gynecology or dermatology.

The gynecological block deals with tumors that can only be found in women, such as ovarian or uterine cancer, as well as breast cancer, which in rare cases also affects men.

The urological block deals with tumors that only affect men, namely prostate and testicular tumors, as well as tumors that affect both sexes, such as renal cell or bladder carcinoma.

In the “Pediatric Oncology” block, the special aspects of childhood leukemia and lymphoma are dealt with, part of which is already discussed in the second year of the focus curriculum. Another important part are solid tumors in childhood, which differ greatly from solid tumors in adulthood, both in their development and in their therapeutic approaches.

The block on ENT oncology is primarily about squamous cell carcinomas of the head and neck such as laryngeal and pharyngeal carcinomas, which are a prime example of the interplay between surgery, chemotherapy and radiation therapy.

The section on dermatology also has a spectrum of different oncological disease pictures: from benign skin tumors ('white skin cancer') to malignant skin tumors (e.g. malignant melanoma, 'black skin cancer') to the less well known lymphomas of the skin.

Other institutes such as pathology, radiology, radiation therapy, nuclear medicine or molecular biology also contribute to all topics so that a comprehensive picture is conveyed.